Dynavax Board Unanimously Recommends Sanofi's $15.50/Share All-Cash Tender Offer for Acquisition
Summary
Sanofi is acquiring Dynavax Technologies Corporation for $15.50 per share in an all-cash tender offer, a transaction unanimously recommended by Dynavax's Board of Directors.
Key Events
-
Acquisition Agreement
Sanofi, through its subsidiary Samba Merger Sub, Inc., is acquiring Dynavax Technologies Corporation for $15.50 per share in an all-cash tender offer.
-
Board Recommendation
Dynavax's Board of Directors unanimously recommends that shareholders tender their shares, citing the offer as advisable and in the best interest of the company and its stockholders.
-
Significant Premium
The $15.50 per share offer price represents a premium of approximately 39% to Dynavax's closing price on December 23, 2025, and 46% to the 90-day volume-weighted average price. The offer price is also near the stock's 52-week high of $15.49.
-
Certainty of Value
The all-cash consideration provides immediate and certain value to shareholders, mitigating risks associated with Dynavax's standalone strategy and pipeline development.
Analysis
The SC 14D9 filing confirms that Dynavax Technologies Corporation's Board of Directors unanimously recommends shareholders accept Sanofi's all-cash tender offer of $15.50 per share. This acquisition provides immediate and certain value to Dynavax shareholders, representing a substantial premium of approximately 39% to the stock's closing price on December 23, 2025, and 46% to the 90-day volume-weighted average price. The board's decision follows an extensive evaluation of strategic alternatives and negotiations, concluding that Sanofi's offer represents the best available option for maximizing shareholder value. The all-cash nature and the structure as a tender offer followed by a short-form merger indicate a high likelihood of timely consummation, offering a clear exit for investors near the stock's 52-week high.
At the time of this filing, DVAX was trading at $15.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $9.20 to $15.49. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.